Views & Analysis Innovative contracting in Europe: a Trojan Horse? By Mary Iyiola & Agnieszka Janska, with additional consultation by Smita Sealey & Barry Farrimond
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
